2016
DOI: 10.1016/j.ajic.2016.02.029
|View full text |Cite
|
Sign up to set email alerts
|

Influence of a 5-year serial infection control and antibiotic stewardship intervention on cardiac surgical site infections

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
14
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(15 citation statements)
references
References 21 publications
1
14
0
Order By: Relevance
“…Many protocols have also been instituted for SSI; however, these have had mixed results. 17,18 This study further demonstrates the potential secondary complications after SSI.…”
Section: Discussionsupporting
confidence: 56%
“…Many protocols have also been instituted for SSI; however, these have had mixed results. 17,18 This study further demonstrates the potential secondary complications after SSI.…”
Section: Discussionsupporting
confidence: 56%
“…Four studies met the eligibility criteria of a cardiac surgery study population, included SSI as an outcome measurement, and used a bundled decolonization treatment strategy with intranasal mupirocin, chlorhexidine, and glycopeptide preoperative antibiotics. The relative risk of SSI for UD was estimated to be 0.35 (95% confidence interval [CI]: 0.26 to 0.46) [11,19]. This relative risk UD variable was derived from two studies that approximated our UD strategy whereby all patients were treated with mupirocin but only MRSA carriers were given vancomycin.…”
Section: Data Sourcesmentioning
confidence: 99%
“…The incidence of SSI in cardiac surgery is across a broad range. This complication is associated with an increase in the duration of hospitalization, mortality, and economic burden (Frenette et al, 2016;Gudbjartsson et al, 2016;Schimmer et al, 2017;Kachel et al, 2020;Liu et al, 2021). The incidence of readmission and mortality for SSI patients is about 46% and 1-14%, respectively, and the cost of treatment is 2.5 times higher than for non-SSI patients (Frenette et al, 2016;Gudbjartsson et al, 2016).…”
Section: Introductionmentioning
confidence: 99%